Precursor Condition
High Grade Cervical Intraepithelial Neoplasia
CI-CAN-00002873Explore in graph →
Precursor14 active trials
- NCIt
- C7670
Loading cancer entity…
Precursor Condition
CI-CAN-00002873Explore in graph →
Clinical trials
50 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03284866 | HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV(COVENANT) | completed | Phase 3 | 536 | AIDS Malignancy ConsortiumNETWORK | 5 | Jan 28, 2026 | clinicaltrials |
| NCT04895020 | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | unknown | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 |
| clinicaltrials |
| NCT04484415 | Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)(APRICITY) | unknown | Phase 3 | 402 | Asieris MediTech (Hong Kong) Co., Ltd.INDUSTRY | 1 | Aug 12, 2022 | clinicaltrials |
| NCT03366493 | The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection | unknown | Phase 3 | 200 | GY Highland Biotech LLCINDUSTRY | 1 | Dec 8, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Jan 28, 2026source: clinicaltrials